HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings Inc
Previous close
$0.75
Day range
$0.70 - $0.76
Year range
$0.49 - $4.28
Market cap
33.12M USD
Avg Volume
868.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.28M | -34.67% |
Net income | -6.26M | 33.09% |
Net profit margin | — | — |
Earnings per share | -0.15 | 57.14% |
EBITDA | — | — |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.48M | -42.33% |
Total assets | 15.50M | -34.59% |
Total liabilities | 14.69M | -18.30% |
Total equity | 812.57K | — |
Shares outstanding | 46.74M | — |
Price to book | 37.70 | — |
Return on assets | -135.84% | — |
Return on capital | 364.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.26M | 33.09% |
Cash from operations | -9.10M | -2.52% |
Cash from investing | — | — |
Cash from financing | 17.02M | -37.60% |
Net change in cash | 7.92M | -56.96% |
Free cash flow | -6.64M | -461.01% |
About
Founded
2018
Headquarters
Website
Employees
14
